MANFREDI, Andreina Teresa
 Distribuzione geografica
Continente #
NA - Nord America 22.484
EU - Europa 14.088
AS - Asia 9.818
SA - Sud America 1.411
Continente sconosciuto - Info sul continente non disponibili 472
AF - Africa 289
OC - Oceania 100
Totale 48.662
Nazione #
US - Stati Uniti d'America 21.881
IT - Italia 7.250
SG - Singapore 2.966
GB - Regno Unito 2.416
CN - Cina 2.393
HK - Hong Kong 1.074
BR - Brasile 1.036
SE - Svezia 977
VN - Vietnam 970
DE - Germania 622
FR - Francia 565
FI - Finlandia 530
BD - Bangladesh 519
TR - Turchia 380
UA - Ucraina 380
RU - Federazione Russa 374
CA - Canada 285
KR - Corea 275
IN - India 264
JP - Giappone 226
NL - Olanda 209
ID - Indonesia 204
MX - Messico 193
IE - Irlanda 163
BG - Bulgaria 161
AR - Argentina 137
AU - Australia 92
ZA - Sudafrica 89
IQ - Iraq 77
PK - Pakistan 76
PL - Polonia 76
AE - Emirati Arabi Uniti 63
TN - Tunisia 58
EC - Ecuador 57
ES - Italia 53
MY - Malesia 51
CO - Colombia 45
CH - Svizzera 43
CL - Cile 43
LT - Lituania 42
PH - Filippine 38
BE - Belgio 36
IR - Iran 33
SA - Arabia Saudita 33
EG - Egitto 31
MA - Marocco 31
PE - Perù 29
VE - Venezuela 29
AT - Austria 28
UZ - Uzbekistan 23
RO - Romania 22
TH - Thailandia 22
HU - Ungheria 21
JO - Giordania 21
NP - Nepal 21
BZ - Belize 20
DZ - Algeria 20
KE - Kenya 19
PT - Portogallo 17
CR - Costa Rica 16
EU - Europa 16
DK - Danimarca 15
TW - Taiwan 15
JM - Giamaica 14
PY - Paraguay 14
TT - Trinidad e Tobago 14
BO - Bolivia 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
HN - Honduras 11
IL - Israele 10
HR - Croazia 9
RS - Serbia 9
GR - Grecia 8
MD - Moldavia 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
AL - Albania 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
LV - Lettonia 7
GT - Guatemala 6
KG - Kirghizistan 6
LB - Libano 6
LU - Lussemburgo 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
UY - Uruguay 6
BY - Bielorussia 5
CY - Cipro 5
KZ - Kazakistan 5
PR - Porto Rico 5
QA - Qatar 5
SI - Slovenia 5
KW - Kuwait 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BB - Barbados 3
Totale 48.143
Città #
Santa Clara 2.079
Singapore 2.033
Ashburn 1.883
Fairfield 1.723
Southend 1.515
Hong Kong 1.043
Woodbridge 941
San Jose 939
Chandler 917
Houston 762
Council Bluffs 683
Chicago 669
Wilmington 638
Hefei 619
Seattle 593
Los Angeles 568
Jacksonville 566
Milan 559
Cambridge 533
Ann Arbor 531
Nyköping 513
Rome 499
London 448
Beijing 424
Helsinki 407
Dearborn 387
The Dalles 348
New York 328
Ho Chi Minh City 291
Salt Lake City 277
Modena 250
Seoul 236
Hanoi 234
San Diego 183
Izmir 181
Dallas 172
Sofia 152
Princeton 147
Buffalo 137
Jakarta 135
Redwood City 132
Tampa 131
Bologna 129
Dublin 128
Florence 123
Lauterbourg 122
Naples 120
Elk Grove Village 119
Eugene 113
Shanghai 113
Bari 108
Palermo 108
São Paulo 108
Columbus 104
Moscow 100
Frankfurt am Main 97
Tokyo 97
Catania 83
Bremen 77
Falls Church 72
Boardman 71
Genoa 70
Toronto 70
Orem 69
Turin 66
Verona 65
Mexico City 64
Phoenix 63
Munich 62
Des Moines 57
Sterling 57
Da Nang 54
Lancaster 52
Padova 50
Montreal 48
Chennai 47
Perth 47
Atlanta 46
Miami 45
Guangzhou 44
Brooklyn 43
San Francisco 42
Cagliari 41
Johannesburg 41
Manchester 40
Mumbai 38
Warsaw 38
Denver 37
Parma 36
Amsterdam 35
Dulles 34
Paris 34
Ankara 33
Detroit 32
Haiphong 32
Ottawa 32
Redondo Beach 31
Dong Ket 30
Messina 30
Salerno 30
Totale 29.583
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.885
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.382
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.346
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 971
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 811
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 496
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 489
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 472
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 454
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 447
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 421
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 413
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 397
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 396
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 392
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 380
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 379
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 377
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 373
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 372
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 369
Current treatment of hepatitis C-associated rheumatic diseases. 367
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 362
Cardiac Involvement in Systemic Vasculitis 361
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 357
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 357
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 354
Aortic pulse wave velocity measurement in systemic sclerosis patients. 351
Scleroderma digital ulcers complicated by infection with fecal pathogens. 350
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 344
Acute exacerbation of interstitial lung disease associated with rheumatic disease 338
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 331
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 331
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 331
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 330
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 328
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 327
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 325
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 324
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 322
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 319
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 316
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 315
Platelet gel in the treatment of severe scleroderma skin ulcers. 315
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 312
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 308
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 306
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 306
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 304
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 299
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 297
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 296
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 295
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 295
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 290
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 289
Cardiovascular risk and prostanoids in systemic sclerosis 288
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 282
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 282
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 280
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 280
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 279
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 278
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 264
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 264
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 262
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 261
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 260
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 257
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 254
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 253
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 253
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 248
Osteomyelitis complicating scleroderma digital ulcers. 248
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 247
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 244
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 244
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 244
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 243
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 241
Procedural pain management in the treatment of scleroderma digital ulcers 238
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 235
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 234
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 234
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 233
NAILFOLD VIDEOCAPILLAROSCOPY FEATURES OF PATIENTS WITH ANTISYNTHETASE SYNDROME 233
Nailfold videocapillaroscopy in antisynthetase syndrome 233
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 227
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 226
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 226
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 224
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 223
Mixed cryoglobulinemia syndrome: where are we going to? 222
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 221
A new chance to treat rheumatoid arthritis lung fibrosis? 217
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 211
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 210
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 210
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 209
Totale 37.228
Categoria #
all - tutte 181.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.003 0 0 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.240 221 274 279 454 574 346 356 548 153 240 343 452
2024/20258.032 334 198 231 585 1.540 1.135 590 418 821 423 794 963
2025/202615.319 800 516 1.011 2.020 3.042 1.045 1.737 647 1.320 1.171 1.098 912
2026/20271.647 561 1.039 47 0 0 0 0 0 0 0 0 0
Totale 48.662